Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener klinische Wochenschrift 21-22/2020

24.07.2020 | main topic

COVID-19: frequently asked questions to the cardiologist

verfasst von: MD, PhD Andreas A. Kammerlander, ao. Univ. Prof. Dr. Julia Mascherbauer

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 21-22/2020

Einloggen, um Zugang zu erhalten
share
TEILEN

Excerpt

In December 2019, a previously unknown betacoronavirus was identified in a cluster of patients with pneumonia in Wuhan, China [ 1]. The pathogen was later named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), sharing similarities with already known SARS strains. The disease caused by SARS-CoV‑2 was named coronavirus disease 2019 (COVID-19) [ 2]. …
Literatur
1.
Zurück zum Zitat Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33. CrossRef Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33. CrossRef
3.
Zurück zum Zitat Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A novel Coronavirus emerging in China—key questions for impact assessment. N Engl J Med. 2020;382(8):692–4. CrossRef Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A novel Coronavirus emerging in China—key questions for impact assessment. N Engl J Med. 2020;382(8):692–4. CrossRef
4.
Zurück zum Zitat Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13. CrossRef Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13. CrossRef
7.
Zurück zum Zitat Guest TM, Ramanathan AV, Tuteur PG, Schechtman KB, Ladenson JH, Jaffe AS. Myocardial injury in critically ill patients. A frequently unrecognized complication. JAMA. 1995;273(24):1945–9. CrossRef Guest TM, Ramanathan AV, Tuteur PG, Schechtman KB, Ladenson JH, Jaffe AS. Myocardial injury in critically ill patients. A frequently unrecognized complication. JAMA. 1995;273(24):1945–9. CrossRef
8.
Zurück zum Zitat Fung G, Luo H, Qiu Y, Yang D, McManus B. Myocarditis. Circ Res. 2016;118(3):496–514. CrossRef Fung G, Luo H, Qiu Y, Yang D, McManus B. Myocarditis. Circ Res. 2016;118(3):496–514. CrossRef
12.
Zurück zum Zitat Yang P, Gu H, Zhao Z, et al. Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury. Sci Rep. 2014;4:7027. CrossRef Yang P, Gu H, Zhao Z, et al. Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury. Sci Rep. 2014;4:7027. CrossRef
19.
Zurück zum Zitat Chieffo A, Stefanini GG, Price S, et al. EAPCI position statement on invasive management of acute coronary syndromes during the COVID-19 pandemic. Eur Heart J. 2020;41(19):1839–51. CrossRef Chieffo A, Stefanini GG, Price S, et al. EAPCI position statement on invasive management of acute coronary syndromes during the COVID-19 pandemic. Eur Heart J. 2020;41(19):1839–51. CrossRef
Metadaten
Titel
COVID-19: frequently asked questions to the cardiologist
verfasst von
MD, PhD Andreas A. Kammerlander
ao. Univ. Prof. Dr. Julia Mascherbauer
Publikationsdatum
24.07.2020
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 21-22/2020
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-020-01696-9